Next Article in Journal
Is Protein Phosphatase Inhibition Responsible for the Toxic Effects of Okadaic Acid in Animals?
Next Article in Special Issue
Continuation of Long-Term Care for Cervical Dystonia at an Academic Movement Disorders Clinic
Previous Article in Journal
Disruption of the Putative Vascular Leak Peptide Sequence in the Stabilized Ricin Vaccine Candidate RTA1-33/44-198
Previous Article in Special Issue
Influence of Botulinum Toxin Therapy on Postural Control and Lower Limb Intersegmental Coordination in Children with Spastic Cerebral Palsy

Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia

Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
Author to whom correspondence should be addressed.
Toxins 2013, 5(2), 249-266;
Received: 10 December 2012 / Revised: 17 January 2013 / Accepted: 23 January 2013 / Published: 4 February 2013
(This article belongs to the Special Issue Clinical Use of Botulinum Toxins)
Local chemodenervation with botulinum toxin (BoNT) injections to relax abnormally contracting muscles has been shown to be an effective and well-tolerated treatment in a variety of movement disorders and other neurological and non-neurological disorders. Despite almost 30 years of therapeutic use, there are only few studies of patients treated with BoNT injections over long period of time. These published data clearly support the conclusion that BoNT not only provides safe and effective symptomatic relief of dystonia but also long-term benefit and possibly even favorably modifying the natural history of this disease. The adverse events associated with chronic, periodic exposure to BoNT injections are generally minor and self-limiting. With the chronic use of BoNT and an expanding list of therapeutic indications, there is a need to carefully examine the existing data on the long-term efficacy and safety of BoNT. In this review we will highlight some of the aspects of long-term effects of BoNT, including efficacy, safety, and immunogenicity. View Full-Text
Keywords: long-term; efficacy; safety; botulinum toxin; dystonia long-term; efficacy; safety; botulinum toxin; dystonia
MDPI and ACS Style

Ramirez-Castaneda, J.; Jankovic, J. Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia. Toxins 2013, 5, 249-266.

AMA Style

Ramirez-Castaneda J, Jankovic J. Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia. Toxins. 2013; 5(2):249-266.

Chicago/Turabian Style

Ramirez-Castaneda, Juan, and Joseph Jankovic. 2013. "Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia" Toxins 5, no. 2: 249-266.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop